Premarket Movers | Ventyx Biosciences Rockets 68%; Critical Metals Surges 11%; Mobileye Jumps over 10%; Strategy Gains 6%

Tiger Newspress
01/07

Eli Lilly is in advanced talks to buy Ventyx Biosciences for more than $1 billion, the Wall Street Journal reported on Tuesday, citing people familiar with the matter. Shares of Ventyx surged 68% in premarket trading following the report, which said the deal could be announced imminently.

Critical Metals shares soared another 11.5% in premarket trading on Wednesday after a 26% rally in prior trading session amid rising speculation over whether the Donald Trump administration will lead the U.S. into acquiring Greenland from Denmark. 

A U.S. acquisition of Greenland stands to benefit Critical Metals, which is developing a major rare earths project– Tanbreez– in the region. 

Mobileye shares jumped over 10% in premarket trading, after the company announced a $900 million acquisition of humanoid robotics startup Mentee Robotics. The deal is expected to combine Mobileye’s AI technology and production capabilities with Mentee’s humanoid robot platform, positioning the company as a leader in both autonomous driving and humanoid robotics markets.

MSCI said on Tuesday it will not proceed with a proposal to exclude digital asset treasury companies, or DATCOs, from its indexes, but will launch a broader consultation on how non-operating companies should be treated. That means Strategy will remain in the firm's global benchmarks for now. Strategy shares jumped 5.7% in premarket trading.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10